Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anish S. Majumdar"'
Autor:
Charan Thej, Sudha Balasubramanian, Mathiyazhagan Rengasamy, Ankita Walvekar, Priyanka Swamynathan, Swathi Sundar Raj, Pradnya Shahani, Siddikuzzaman, Udaykumar Kolkundkar, Raviraja N. Seetharam, Pawan Kumar Gupta, Anish S. Majumdar
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-16 (2021)
Abstract Background We have previously demonstrated that a pooled population of bone marrow-derived, allogeneic mesenchymal stromal cells (BMMSC), Stempeucel®-1, produced under good manufacturing practices (GMP) conditions, showed clinical efficacy
Externí odkaz:
https://doaj.org/article/c5026693bcfa48d0975404e5e253297b
Autor:
Mathiyazhagan Rengasamy, Gurbind Singh, Noor Atiqah Fakharuzi, Siddikuzzaman, Sudha Balasubramanian, Priyanka Swamynathan, Charan Thej, Gopinath Sasidharan, Pawan Kumar Gupta, Anjan Kumar Das, Ahmad Zuhairi Abd Rahman, Kamal Shaik Fakiruddin, Lim Moon Nian, Zubaidah Zakaria, Anish S. Majumdar
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-12 (2017)
Abstract Background Mesenchymal stromal cells (MSCs) from various tissues have shown moderate therapeutic efficacy in reversing liver fibrosis in preclinical models. Here, we compared the relative therapeutic potential of pooled, adult human bone mar
Externí odkaz:
https://doaj.org/article/301918f2e34643b3bbd58aa0a7ecd94e
Autor:
Pablo Bora, Anish S. Majumdar
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-10 (2017)
Abstract Adipose/fat tissue provides an abundant source of stromal vascular fraction (SVF) cells for immediate administration and can also give rise to a substantial number of cultured, multipotent adipose-derived stromal cells (ADSCs). Recently, bot
Externí odkaz:
https://doaj.org/article/eb5fdb6bf8064fad93b5df2f4ff9b81b
Autor:
Wendy L. Trigona, Cynthia M. Porter, Eda T. Bloom, Anish S. Majumdar, Judith A. Horvath–Arcidiacono
Publikováno v:
Antioxidantsredox signaling. 9(6)
Pluripotent human embryonic stem cells (hESCs) may provide a potential source of cellular therapies, but as allogeneic cells may require evading the recipient's immune response. Using an NIH-registry hESC line, it was found that undifferentiated hESC